Clinical trial · Observational
Characteristics and Outcomes of Patients With Hematological Malignancies
Characteristics and Outcomes of Patients With Hematological Malignancies at Main Assuit University Hospital : A Single Centre Study
NCT06402175CI-TRIAL-00077736not yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The pattern of hematological malignancies (HMs) in developing countries and developed countries differs. Among the different types of cancers, leukemia, lymphoma, and multiple myeloma appear to have greatly increased in frequency.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Haematologic Neoplasm | Hematopoietic and Lymphoid Cell Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| follow up | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- overall survival rate
- timeFrame
- 5 years
- description
- Assessment of overall survival of hematological malignancies at Assiut university Hospital * Estimate rate of non-relapse mortality. * Estimate rate of complete remission. * Estimate rate of refractory disease. * Estimate the rate of relapsed diseases.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Adult patients of Hematological malignancies (≥18 years) Exclusion Criteria: * patients who have started diagnosis and treatment for malignancy outside Assiut university. * Age less than 18 years
References
Publications (0)
Data not yet available
No reference posted for this study.